Stay updated on IMP321 for Advanced Solid Tumors Clinical Trial.
Sign up to get notified when there's something new on the IMP321 for Advanced Solid Tumors Clinical Trial. page.

Latest updates to the IMP321 for Advanced Solid Tumors Clinical Trial. page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check15 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check22 days agoChange DetectedThe page has removed the mention of 'eftilagimod Alpha' in the title of the section regarding the feasibility and safety of IMP321 for advanced stage solid tumors.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check58 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a significant revision. The phrase 'Here’s how you know' has been removed and replaced with a similar phrase.SummaryDifference1.0%
- Check65 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 13, 2025. However, the removal of the date March 25, 2025, does not significantly impact the core content.SummaryDifference1.0%
Stay in the know with updates to IMP321 for Advanced Solid Tumors Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the IMP321 for Advanced Solid Tumors Clinical Trial. page.